Founded in 1993
  Year: 2009 | Volume: 17 | Issue: 3-4 | Pages: 78-79
  Review Article
  PHARMACOECONOMIC ANALYSIS OF ANTINEOPLASTICS AT THE ONCOLOGY INSTITUTE OF VOJVODINA FROM 2005 TO 2008
Maja S. Ilic
  DOI: 10.2298/AOO0904078I
  Abstract:
  Contemporary cancer chemotherapy need to be active against malignant cell (selectivity), to be based on the molecular biology of the cancer cell, to enhance immune response to cancer, and to stop development of resistance to drug. Research in this field is expensive, as well as the cost of newly discovered drugs. Targeted therapies are registered in the Republic of Serbia and their applications are controlled by the state authority. At the Oncology Institute of Vojvodina smaller number of patients was treated with targeted therapy than with classical chemotherapy. However, our costs for treating patients with monoclonal therapies are at the level of those worldwide.
  Key words: Economics, Pharmaceutical; Medical Oncology; Drug Delivery Systems;Amyloid Precursor Protein Secretases;Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase
  Read full text in PDF [Full Text]
Next article

Previous article

Table of contents

Browse all Volumes

Search all Volumes
By keywords
By authors

  Search AoO for:
 

  Related articles in AoO:
 
About Journal | Editorial Board | Editorial Policy | Instructions for Authors | Open Access | Advertising | Payed issues | Article Submission Charge | Contact
Founder, owner and publisher: Oncology Institute of Vojvodina, Serbia
Online since 1997 (Abstracts only); 2000 (Abstracts and Full text)
ISSN: 0354-7310 eISSN: 1450-9520